Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma
Clinical trial NCT02360579 · COMPLETED
Trial details
- NCT number
- NCT02360579
- Sponsor
- Iovance Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-24
- Primary completion
- 2024-10-24
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.